Value of non-reimbursed drug sales in Poland 2019-2024
In 2024, the value of non-reimbursed drug sales in Poland amounted to nearly 15.7 billion zloty, increasing by 16.5 percent compared to the previous year.
In 2024, the value of non-reimbursed drug sales in Poland amounted to nearly 15.7 billion zloty, increasing by 16.5 percent compared to the previous year.
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Overview
Manufacturing
Trade
Sales
Products & prices
OTC market
R&D and Clinical trials
Pharmacies
Drugstores
Companies
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.